Literature DB >> 92563

Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines.

G W Read, E F Kiefer.   

Abstract

Benzalkonium chloride (BAC) is a mixture of quaternary benzyldimethylalkylammonium chlorides which was found to inhibit histamine release induced by polyamines (48/80, ATP, bradykinin, curare, guanethidine, polylysine, polymyxin B, poly-THIQ, protamine, stilbamidine or substance P), but not that caused by antigens, concanavalin A, dextran, lonophores (A23187 or X-537A), enzymes (chymotrypsin or phospholipase C), monoamines (dextromethorphan, meperidine or chlorpromazine) or detergents (decylamine, Triton X-100 or a fire ant venom alkylpiperidine). Inhibition by 1.5 and 3 microgram of BAC per ml caused parallel shifts of the 48/80 dose-response curves to the right with no loss of efficacy, indicating that the antagonism was surmountable. Phospholipase C was partially inhibited by BAC, but Triton X-100 also inhibited phospholipase C (but not 48/80), indicating that the inhibition of phospholipase C by BAC was probably a nonspecific, detergent effect. BAC caused histamine release by itself at concentrations over 5 microgram/ml. Heat inactivation (50 degrees C for 15 min) of the mast cells did not prevent this release, suggesting a lytic mechanism for this action. Structure-activity relations studies on various members of the BAC family for their ability to inhibit 48/80-induced histamine release indicated that benzyldimethyltridecylammonium chloride was the most potent.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 92563

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  26 in total

1.  Natural polyamines stimulate G-proteins.

Authors:  J L Bueb; A Da Silva; M Mousli; Y Landry
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

2.  Effects of antihistamines on isolated rat peritoneal mast cells and on model membrane systems.

Authors:  H Y Lau; F L Pearce
Journal:  Agents Actions       Date:  1990-03

3.  Modulation of histamine release from rat peritoneal mast cells by non-cytotoxic concentrations of the detergents Cremophor El (oxethylated castor oil) and Triton X100. A possible explanation for unexpected adverse drug reactions?

Authors:  M Ennis; W Lorenz; W Gerland
Journal:  Agents Actions       Date:  1986-04

Review 4.  Mast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives.

Authors:  W M Purcell; C K Atterwill
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

Review 5.  Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).

Authors:  L K Golightly; S S Smolinske; M L Bennett; E W Sutherland; B H Rumack
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 May-Jun

6.  Stimulation by McN-A-343 and blockade by telenzepine of acid secretion in the mouse isolated stomach at histamine-liberating cells.

Authors:  W Kromer; E Baron; M Beinborn; M Eltze; W A Simon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

7.  Action of the SP2-11 and SP3-11 fragments of substance P on rat peritoneal mast cells.

Authors:  W Piotrowski; M Mead; J C Foreman
Journal:  Agents Actions       Date:  1987-04

8.  Characteristics of beta-endorphin-induced histamine release from rat serosal mast cells. Comparison with neurotensin, dynorphin and compound 48/80.

Authors:  A Sydbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

9.  On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin.

Authors:  W Piotrowski; J C Foreman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-12       Impact factor: 3.000

10.  Anaphylaxis caused by benzalkonium in a nebulizer solution.

Authors:  Sang-Hoon Kim; Youngsoo Ahn
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.